chr6-147262345-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001127715.4(STXBP5):c.622G>A(p.Glu208Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000025 in 1,561,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001127715.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151814Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000516 AC: 11AN: 212980Hom.: 0 AF XY: 0.0000515 AC XY: 6AN XY: 116430
GnomAD4 exome AF: 0.0000163 AC: 23AN: 1409982Hom.: 0 Cov.: 27 AF XY: 0.0000171 AC XY: 12AN XY: 700478
GnomAD4 genome AF: 0.000105 AC: 16AN: 151930Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.622G>A (p.E208K) alteration is located in exon 6 (coding exon 6) of the STXBP5 gene. This alteration results from a G to A substitution at nucleotide position 622, causing the glutamic acid (E) at amino acid position 208 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at